Anatomy and Cell Biology

Korean Association of Anatomists (대한해부학회)
권호 표지
DOI QR코드

DOI QR Code

Recovered changes in the spleen by agmatine treatment after transient cerebral ischemia

  • Uranchimeg, D. (Department of Anatomy, Yonsei University College of Medicine) ;
  • Kim, Jae-Hwan (Department of Anatomy, Yonsei University College of Medicine) ;
  • Kim, Jae-Young (Department of Anatomy, Yonsei University College of Medicine) ;
  • Lee, Won-Taek (Department of Anatomy, Yonsei University College of Medicine) ;
  • Park, Kyung-Ah (Department of Anatomy, Yonsei University College of Medicine) ;
  • Batbaatar, G. (Health Sciences University of Mongolia) ;
  • Tundevrentsen, S. (Health Sciences University of Mongolia) ;
  • Amgalanbaatar, D. (Health Sciences University of Mongolia) ;
  • Lee, Jong-Eun (Department of Anatomy, Yonsei University College of Medicine)
  • Received : 2010.02.04
  • Accepted : 2010.03.05
  • Published : 2010.03.30
⟨ Previous Next ⟩

Abstract

Stroke or cerebrovascular injury is the leading cause of disability and the third leading cause of deaths worldwide. After the initial ischemic injury, sympathetic signals are transmitted to the spleen and a compromised blood-brain barrier, coupled with expression of adhesion molecules by the vascular endothelial cells permits an influx of peripheral immune cells. This influx of peripheral immune cells into the brain exacerbates the local brain inflammatory response, leading to enhanced neurodegeneration. Agmatine is a primary amine formed by decarboxylation of L-arginine synthesized in the mammalian brain. In this study, we determined the effect of agmatine on the immune response in the spleen after transient cerebral ischemia. Twenty-three hours after transient cerebral ischemia, the white pulp area was reduced and the number of $CD11b^+$ macrophages and $CD4^+CD25^+$ regulatory T cells (T reg cells) were increased in the spleens in the experimental group as a result of alteration of the immune response in the spleen, as regulated by inflammatory cytokines. In the agmatine treatment group (100 mg/kg IP), the contraction of white pulp was diminished and the number of $CD11b^+$ macrophages and $CD4^+CD25^+T$ reg cells were decreased. Twenty-three hours after transient cerebral ischemia, the brain infarction area was significantly reduced ($5.51{\pm}1.63%$ of the whole brain) in the agmatine treatment group compared to $15.02{\pm}4.28%$ of the whole brain in the experimental control group. These results suggest that agmatine treatment can reduce brain infarction through minimizing neuroinflammation and can lessen the danger of post-stroke infection from depression of the immune system after stroke.

Keywords

Acknowledgement

Supported by : Korea Science and Engineering Foundation (KOSEF)

References

  1. Abbas AK, Lichtman AH, Pillai S. (2007). Cellular and molecular immunology, 6th Ed., pp. 192-196; 252-253
  2. Auguet M, Viossat I, Marin JG, Chabrier PE. (1995). Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 69: 285-287 https://doi.org/10.1254/jjp.69.285
  3. Batbaatar G. (2007). Basic immunology, 4th Ed., pp. 67-75
  4. Emsley HC, Smith CJ, Gavin CM, et al. (2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139: 93-101 https://doi.org/10.1016/S0165-5728(03)00134-6
  5. Garcia Y, Breen A, Burugapalli K, Dockery P, Pandit A. (2007). Stereological methods to assess tissue response for tissueengineered scaff olds. Biomaterials 28: 175-186 https://doi.org/10.1016/j.biomaterials.2006.08.037
  6. Gendron A, Teitelbaum J, Cossette C, et al. (2002). Temporal eff ects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955: 85-97 https://doi.org/10.1016/S0006-8993(02)03368-1
  7. Kim JH, Lee YW, Kim JY, Lee WT, Park KA, Lee JE. (2008). The effect of agmatine on expression of MMP2 and MMP9 in Cerebral ischemia. Korean J Anat 41: 97-104
  8. Kim JH, Yenari MA, Giff ard RG, Cho SW, Park KA, Lee JE. (2004). Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol 189: 122-130 https://doi.org/10.1016/j.expneurol.2004.05.029
  9. Kim SY, Choi KC, Chang MS, et al. (2006). The dopamine D2 receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. J Neurosci 26: 4567-4576 https://doi.org/10.1523/JNEUROSCI.5236-05.2006
  10. Kohm AP, Sanders VM. (2001). Norepinephrine and beta 2-adrenergic re ceptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53: 487-525
  11. Lee JE, Yenari MA, Sun GH, et al. (2001). Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp Neurol 170: 129-139 https://doi.org/10.1006/exnr.2000.7614
  12. Levings MK, Sangregorio R, Roncarolo MG. (2001). Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193: 1295-1302 https://doi.org/10.1084/jem.193.11.1295
  13. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969 https://doi.org/10.1126/science.7906055
  14. Lucas SM, Rothwell NJ, Gibson RM. (2006). The role of infl ammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1): S232-240
  15. Molderings GJ, Bonisch H, Hammermann R, Gothert M, Bruss M. (2002). Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha (2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem Int 40: 157-167 https://doi.org/10.1016/S0197-0186(01)00076-6
  16. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. (2006). Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26: 654-665 https://doi.org/10.1038/sj.jcbfm.9600217
  17. Piletz JE, Chikkala DN, Ernsberger P. (1995). Comparison of the properties of agmatine and endogenous clonidinedisplacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 272: 581-587
  18. Prass K, Meisel C, Hoflich C, et al. (2003). Stroke-induced immu no deficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198: 725-736 https://doi.org/10.1084/jem.20021098
  19. Regunathan S, Piletz JE. (2003). Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 1009: 20-29 https://doi.org/10.1196/annals.1304.002
  20. Reynolds IJ. (1990). Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 255: 1001-1007
  21. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164
  22. Stewart IB, McKenzie DC. (2002). The human spleen during physiological stress. Sports Med 32: 361-369 https://doi.org/10.2165/00007256-200232060-00002
  23. Takahashi T, Kuniyasu Y, Toda M, et al. (1998). Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10: 1969-1980 https://doi.org/10.1093/intimm/10.12.1969
  24. Thornton AM, Shevach EM. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296 https://doi.org/10.1084/jem.188.2.287
  25. Vendrame M, Gemma C, Pennypacker KR, et al. (2006). Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 199: 191-200 https://doi.org/10.1016/j.expneurol.2006.03.017
  26. West MJ. (1993). New stereological methods for counting neurons. Neurobiol Aging 14: 275-285 https://doi.org/10.1016/0197-4580(93)90112-O
  27. Wolf BC, Neiman RS. (1987). Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol 1: 77-80
  28. Yang XC, Reis DJ. (1999). Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288: 544-549

Cited by

  1. The pharmacological importance of agmatine in the brain vol.36, pp.1, 2010, https://doi.org/10.1016/j.neubiorev.2011.08.006
  2. Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential vol.133, pp.3, 2012, https://doi.org/10.1016/j.pharmthera.2011.12.005
  3. Retroviral expression of human arginine decarboxylase reduces oxidative stress injury in mouse cortical astrocytes vol.15, pp.None, 2014, https://doi.org/10.1186/1471-2202-15-99
  4. Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism vol.9, pp.3, 2010, https://doi.org/10.1007/s12602-017-9262-1
  5. Communication Between the Microbiota and Mammalian Immunity vol.72, pp.1, 2010, https://doi.org/10.1146/annurev-micro-090817-062307
  6. Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target? vol.39, pp.6, 2010, https://doi.org/10.1177/0271678x19841443
  7. The “Dialogue” Between Central and Peripheral Immunity After Ischemic Stroke: Focus on Spleen vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.792522